Mereo BioPharma Shares Higher After Results in Emphysema Study - MarketWatch

Retrieved on: 2022-05-09 21:27:19

Tags for this article:

Click the tags to see associated articles and topics

Mereo BioPharma Shares Higher After Results in Emphysema Study - MarketWatch. View article details on hiswai:

Excerpt

By Michael Dabaie Mereo BioPharma Group plc shares rose 7.4% to 62.5 cents premarket after the clinical-stage company said efficacy and safety ...

Article found on: www.marketwatch.com